Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 101–200 of 965
Hu, R., Xia, C., Butfiloski, E. J., & Clare-Salzler, M. J. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.06.003 · Cited by 110
“In this study, the authors also found that these systemic infections were dependent on glucose transportation in intestinal epithelial cells because the glucose transporter GLUT2 deletion protected mice from pathogen invasion [46].”
BackgroundIntestinal Bacterial Translocation Contributes to Diabetic Kidney Disease
Linh, H. T., Iwata, Y., Senda, Y., Takemori, Y., Nakade, Y., Oshima, M., Nakagawa, S., Ogura, H., Sato, K., Minami, T., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060843 · Cited by 106
“reported that hyperglycemia affected the integrity of tight (ZO-1) and adherence (E-cadherin) junction, then led to barrier disruption.(13) In our study, decreased expression of ZO-1 contributed to an increase in gut permeability, in in vivo diabetic mice and in in vitro high glucose-stimulated IECs.”
BackgroundSilva, D., Viana, S., Carvalho, E., Reis, F., & Matafome, P. N. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03262-3 · Cited by 111
Metabolic Adaptations to Infections at the Organismal Level
Troha, K., & Ayres, J. S. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.001 · Cited by 103
“One of the best characterized ways the microbiota (39) can promote protection against pathogenic infections is by mediating antagonistic defenses that prevent pathogen colonization or support pathogen killing (Figure 1).”
BackgroundPosteraro, B., Torelli, R., Vella, A., Leone, P. M., Angelis, G. D., Carolis, E. D., Ventura, G., Sanguinetti, M., & Fantoni, M. (2020) · Journal of Fungi · doi:10.3390/jof6030163 · Cited by 107
“, Enterobacterales or Candida species) to reach the bloodstream and then to spread systemically [13].”
BackgroundCitrus flavonoids and the intestinal barrier: Interactions and effects
Wang, M., Zhao, H., Wen, X., Ho, C., & Li, S. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12652 · Cited by 110
The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease
Chi, M., Ma, K., Wang, J., Ding, Z., Li, Y., Zhu, S., Liang, X., Zhang, Q., Song, L., & Liu, C. (2021) · Journal of Immunology Research · doi:10.1155/2021/5516035 · Cited by 113
Gut Dysfunction and Non-alcoholic Fatty Liver Disease
Grabherr, F., Grander, C., Effenberger, M., Adolph, T. E., & Tilg, H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00611 · Cited by 96
“Hyperglycemia impairs epithelial integrity (46) and could exhibit a relevant factor influencing composition of the intestinal microbiota.”
BackgroundGut mycobiomes are altered in people with type 2 Diabetes Mellitus and Diabetic Retinopathy
Jayasudha, R., Das, T., Chakravarthy, S. K., Prashanthi, G. S., Bhargava, A., Tyagi, M., Rani, P. K., Pappuru, R. R., & Shivaji, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243077 · Cited by 102
“[87] demonstrated using a mouse model of type 1 diabetes mellitus that high blood sugar (hyperglycemia) causes a leaky gut barrier and changes the gut microbiota.”
BackgroundZhao, L., Lou, H., Peng, Y., Chen, S., Fan, L., & Li, X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108418 · Cited by 102
Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction
Lv, Q., Xu, D., Zhang, X., Yang, X., Zhao, P., Cui, X., Liu, X., Yang, W. Q., Yang, G., & Xing, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.524236 · Cited by 106
“Hyperglycemia drives intestinal barrier permeability in mouse models of obesity and diabetes, leading to the systemic influx of microbial products and enhanced systemic infection and inflammation (Thaiss et al., 2018).”
BackgroundFecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome
Leshem, A., Horesh, N., & Elinav, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01341 · Cited by 103
“Additionally, an intervention targeting the host interface of the host-microbiome gut niche may diminish some deleterious inflammatory consequences of obesity and diabetes (50).”
BackgroundSelf-citationMicronutrients impact the gut microbiota and blood glucose
Barra, N. G., Anhê, F. F., Cavallari, J. F., Singh, A. M., Chan, D. Y., & Schertzer, J. D. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0081 · Cited by 100
Zhao, H., Li, M., Liu, L., Li, D., Zhao, L., Wu, Z., Zhou, M., Jia, L., & Yang, F. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123241 · Cited by 98
Nutrition Regulates Innate Immunity in Health and Disease
Nobs, S. P., Zmora, N., & Elinav, E. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120919-094440 · Cited by 102
“High levels of glucose impair intestinal barrier integrity and promote translocation of components of the microbiota (181), likely promoting colitis.”
BackgroundInfluentialSelf-citationThe role of stress kinases in metabolic disease
Nikolić, I., Leiva, M., & Sabio, G. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00418-5 · Cited by 96
How Comorbidities Shape Cancer Biology and Survival
Panigrahi, G., & Ambs, S. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.010 · Cited by 97
Beardsall, K., Thomson, L. M., Guy, C., Iglesias‐Platas, I., van Weissenbruch, M. M., Bond, S. J., Allison, A., Kim, S.-W., Petrou, S., Pantaleo, B., et al. (2021) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30367-9 · Cited by 95
Liu, Y., Gao, Y., Ma, F., Sun, M., Mu, G., & Tuo, Y. (2020) · Food & Function · doi:10.1039/d0fo00439a · Cited by 96
Valdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.016 · Cited by 89
Self-citationSugars and Gastrointestinal Health
Arnone, D., Chabot, C., Heba, A.-C., Kökten, T., Caron, B., Hansmannel, F., Dreumont, N., Ananthakrishnan, A. N., Quilliot, D., & Peyrin‐Biroulet, L. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.011 · Cited by 105
Lung dendritic-cell metabolism underlies susceptibility to viral infection in diabetes
Nobs, S. P., Kolodziejczyk, A. A., Adler, L. N., Horesh, N., Botscharnikow, C., Herzog, E., Mohapatra, G., Hejndorf, S., Hodgetts, R. J., Spivak, I., et al. (2023) · Nature · doi:10.1038/s41586-023-06803-0 · Cited by 95
“Mice received 100 mg kg −1 STZ (Sigma) in PBS or PBS as vehicle con-trol via an intraperitoneal injection on days 0 and 1 and were then allowed to recover for 2 weeks before further experimental steps 31 .”
Self-citationConrey, P. E., Denu, L., O’Boyle, K. C., Rozich, I., Green, J., Maslanka, J. R., Lubin, J., Duranova, T., Haltzman, B. L., Gianchetti, L., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.ade2335 · Cited by 95
FTZ polysaccharides ameliorate kidney injury in diabetic mice by regulating gut-kidney axis
Lan, T., Tang, T., Li, Y., Duan, Y., Yuan, Q., Liu, W., Ren, Y., Li, N., Liu, X., Zhang, Y., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154935 · Cited by 96
Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance
Forgie, A. J., Fouhse, J. M., & Willing, B. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01802 · Cited by 95
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Hyun, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179139 · Cited by 90
Gut Microbiota and Bone Diseases: A Growing Partnership
Chen, Y., Wang, X., Zhang, C., Liu, Z., Li, C., & Ren, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.877776 · Cited by 96
The intestinal immune system and gut barrier function in obesity and ageing
Shemtov, S. J., Emani, R., Bielska, O., Covarrubias, A. J., Verdin, E. M., Andersen, J. K., & Winer, D. A. (2022) · FEBS Journal · doi:10.1111/febs.16558 · Cited by 87
Dysregulation of the epithelial barrier by environmental and other exogenous factors
Mitamura, Y., Ogulur, I., Pat, Y., Rinaldi, A. O., Ardicli, O., Cevhertas, L., Brüggen, M., Traidl‐Hoffmann, C., Akdis, M., & Akdis, C. A. (2021) · Contact Dermatitis · doi:10.1111/cod.13959 · Cited by 85
“intestinal barrier dysfunction and enhanced dissemination of enteric infection in a mouse model of type I diabetes mellitus induced by administering streptozotocin.(69) Similarly, Yu et al reported that high”
BackgroundMicrobial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Liu, M., Nieuwdorp, M., de Vos, W. M., & Rampanelli, E. (2022) · Metabolites · doi:10.3390/metabo12090834 · Cited by 94
“For instance, whereas perturbations of the microbial taxonomic and functional profiles precede the onset of diabetes, hyperglycemia has been shown to provoke intestinal permeability, which can affect the mucosal immunoreactivity towards gut microbes [141,142].”
BackgroundZhang, S., Wang, L., Xu, T., & Zhang, X. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c21786 · Cited by 85
Singh, H., Miyamoto, S., Darshi, M., Torralba, M., Kwon, K., Sharma, K., & Pieper, R. (2020) · Microorganisms · doi:10.3390/microorganisms8091347 · Cited by 86
Twardowska, A., Makaro, A., Binienda, A., Fichna, J., & Sałaga, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063204 · Cited by 95
“Recently, it has been suggested that chronically increased levels of glucose in the blood may also lead to the disruption of TJ proteins [42].”
BackgroundVujkovic-Cvijin, I., Welles, H. C., Ha, C. W. Y., Huq, L., Mistry, S., Brenchley, J. M., Trinchieri, G., Devkota, S., & Belkaid, Y. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl3927 · Cited by 91
Advanced Glycation End-Products and Their Effects on Gut Health
Phuong-Nguyen, K., McNeill, B. A., Aston‐Mourney, K., & Rivera, L. R. (2023) · Nutrients · doi:10.3390/nu15020405 · Cited by 89
Recent advances in the epithelial barrier theory
Pat, Y., Yazıcı, D., D’Avino, P., Li, M., Ardıçlı, S., Ardıçlı, Ö., Mitamura, Y., Akdiş, M., Dhir, R., Nadeau, K. C., et al. (2024) · International Immunology · doi:10.1093/intimm/dxae002 · Cited by 95
“(ii) Systemic diseases with gut or lung barrier defect and dysbiosis [obesity (129, 130), diabetes mellitus (131, 132), rheumatoid arthritis (133), multiple sclerosis (134), fatty liver (135), autoimmune hepatitis (136), systemic lupus erythematosus, and anky-losing spondylitis (137)].”
BackgroundSikora, M., Stec, A., Maciejewska, M., Waśkiel‐Burnat, A., Zaremba, M., Olszewska, M., & Rudnicka, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071021 · Cited by 88
A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
Kim, E. R., Park, J. S., Kim, J. H., Oh, J. Y., Oh, I. J., Choi, D. H., Lee, Y. S., Park, I. S., Kim, S., Lee, D. H., et al. (2021) · Hepatology · doi:10.1002/hep.32235 · Cited by 82
“Diet, obesity, and hyperglycemia are known to influence the gut microbiome and intestinal structure, leading to increased levels of bacterial endotoxins and proinflammatory cytokines in portal circulation.[10,11] There is increasing attention toward the mechanistic role of gut microbiome on NASH,[12] and strategies ar…”
BackgroundExcessive Gluconeogenesis Causes the Hepatic Insulin Resistance Paradox and Its Sequelae
Onyango, A. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12294 · Cited by 93
“Increased intestinal barrier permeability, which can be induced by blood glucose dysregulation, promotes the progression of NAFLD, through delivery of gut-derived harmful factors such as endotoxin to the liver [149, 150].”
BackgroundDirect and indirect effects of pathogenic bacteria on the integrity of intestinal barrier
Shu, L.-Z., Ding, Y.-D., Xue, Q.-M., Cai, W., & Deng, H. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231176427 · Cited by 89
Lin, X., Song, D., Shao, T., Xue, T., Hu, W., Jiang, W., Zou, X., & Liu, N. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202311637 · Cited by 79
Riedel, S., Pheiffer, C., Johnson, R., Louw, J., & Muller, C. J. F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.833544 · Cited by 90
The intestinal microbiome and Alzheimer's disease: A review
Li, Z., Zhu, H., Zhang, L., & Qin, C. (2018) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12033 · Cited by 82
“integrity, resulting in systemic influx of microbial products and enhanced dissemination of enteric infection.(105)”
BackgroundLee, H., An, J., Kim, J., Choi, D., Song, Y., Lee, C., Kong, H., Kim, S. B., & Kim, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.858192 · Cited by 82
Bioceramic Scaffolds with Antioxidative Functions for ROS Scavenging and Osteochondral Regeneration
Deng, C., Zhou, Q., Zhang, M., Li, T., Chen, H., Xu, C. W., Feng, Q., Wang, X., Yin, F., Cheng, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202105727 · Cited by 82
Antibiotics damage the colonic mucus barrier in a microbiota-independent manner
Sawaed, J., Zelik, L., Levin, Y., Feeney, R. H., Naama, M., Gordon, A., Zigdon, M., Rubin, E., Telpaz, S., Modilevsky, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp4119 · Cited by 81
Crakes, K. R., Rocha, C. S., Grishina, I., Hirao, L. A., Napoli, E., Gaulke, C. A., Fenton, A. N., Datta, S., Arredondo, J., Marco, M. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908977116 · Cited by 81
“mitochondrial dysfunction and this can also increase risk of systemic infection (36).”
BackgroundXie, C., Qi, C., Zhang, J., Wang, W., Meng, X., Aikepaer, A., Lin, Y., Su, C., Liu, Y., Feng, X., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116791 · Cited by 76
Dietary Patterns, Carbohydrates, and Age-Related Eye Diseases
Francisco, S. G., Smith, K., Aragonès, G., Whitcomb, E. A., Weinberg, J., Wang, X., Bejarano, E., Taylor, A., & Rowan, S. (2020) · Nutrients · doi:10.3390/nu12092862 · Cited by 76
Gut microbiota mediated hypoglycemic effect of Astragalus membranaceus polysaccharides in db/db mice
Song, Q., Cheng, S. W., Li, D., Cheng, H., Lai, Y. S., Han, Q., Wu, H. Y., Shaw, P. C., & Zuo, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043527 · Cited by 74
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
Wang, H., Zhang, H., Gao, Z., Zhang, Q., & Gu, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.854885 · Cited by 69
“Thass CA (Thaiss et al., 2018) firmly believed glucose as an orchestrator of intestinal barrier function.”
BackgroundBuicu, A., Cernea, S., Benedek, I., Buicu, C.-F., & Benedek, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081545 · Cited by 72
Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease
Aragonès, G., González-García, S., Aguilar, C., Richart, C., & Auguet, T. (2019) · BioMed Research International · doi:10.1155/2019/8507583 · Cited by 78
Systemically circulating bacterial extracellular vesicles: origin, fate, and function
Hendrix, A., & Wever, O. D. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.12.012 · Cited by 71
Komori, K., Ihara, E., Minoda, Y., Ogino, H., Sasaki, T., Fujiwara, M., Oda, Y., & Ogawa, Y. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-5470-8 · Cited by 74
Lin, Y., Luck, H., Khan, S. M., Schneeberger, P. H. H., Tsai, S. J., Clemente‐Casares, X., Lei, H., Leu, Y., Chan, Y. T., Chen, H., et al. (2019) · International Journal of Obesity · doi:10.1038/s41366-019-0340-1 · Cited by 76
Flavonoids modulate tight junction barrier functions in hyperglycemic human intestinal Caco-2 cells
Sharma, S., Tripathi, P., Sharma, J., & Dixit, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.110792 · Cited by 67
The Role of Hyperglycemia in Endometrial Cancer Pathogenesis
Byrne, F. L., Martin, A. R., Kosasih, M., Caruana, B. T., & Farrell, R. (2020) · Cancers · doi:10.3390/cancers12051191 · Cited by 69
“A recent study in mice has provided novel insight into how hyperglycemia may impair intestinal barrier permeability by causing altered gut microbiota composition (dysbiosis), leading to systemic dissemination of microbial products and inflammation [112].”
BackgroundGut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Fungal lysozyme leverages the gut microbiota to curb DSS-induced colitis
Larsen, I., Jensen, B. A. H., Bonazzi, E., Choi, B. S.-Y., Kristensen, N. N., Schmidt, E. G. W., Sünderhauf, A., Morin, L., Olsen, P., Hansen, L. B. S., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1988836 · Cited by 70
Astaxanthin-Shifted Gut Microbiota Is Associated with Inflammation and Metabolic Homeostasis in Mice
Wu, L., Lyu, Y., Ramkumar, S., Wu, J., Ojo, B. A., Tang, M., El-Rassi, G. D., Metzinger, K., Smith, B. J., Lucas, E. A., et al. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa222 · Cited by 73
“subsequent immunoblotting analysis (26).”
Yang, T., Yang, H., Cai, H., Wang, H., Chen, S., Hu, Y., Jiang, Z., Yu, Q., Wang, Z., Qian, S., et al. (2020) · Food & Function · doi:10.1039/d0fo01954b · Cited by 69
Bastos, R. M. C., Simplício-Filho, A., Sávio-Silva, C., de Oliveira, L. F. V., Cruz, G. N. F., Sousa, E. H., Noronha, I. L., Mangueira, C. L. P., Quaglierini-Ribeiro, H., Josefi-Rocha, G. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073842 · Cited by 70
“Notably, intestinal homeostasis is maintained by the dynamic interaction between luminal microorganisms and the intestinal epithelium [64], so hyperglycemia may predispose individuals to intestinal barrier dysfunction [65].”
BackgroundZong, L., Teng, R., Zhang, H., Liu, W., Feng, Y., Lu, Z., Zhou, Y., Fan, Z., Li, M., & Pu, X. (2024) · Advanced Science · doi:10.1002/advs.202406022 · Cited by 65
El-Rous, M. A., Saber, S., Raafat, E. M., & Ahmed, A. A. E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00818-7 · Cited by 65
Varghese, E., Samuel, S. M., Líšková, A., Kubatka, P., & Büsselberg, D. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009634 · Cited by 68
Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
Mantovani, A., Dalbeni, A., Peserico, D., Cattazzo, F., Bevilacqua, M., Salvagno, G. L., Lippi, G., Targher, G., Danese, E., & Fava, C. (2021) · Metabolites · doi:10.3390/metabo11070453 · Cited by 68
“Another possible explanation for the differences in plasma BA profiles we observed between patients with and those without T2DM might be due to presence of altered intestinal barrier permeability (thus contributing to increase the permeability to various luminal factors, including BAs), which has been experimentally d…”
BackgroundLiu, P., Zhou, W., Xu, W., Peng, Y., Yan, Y., Lu, L., Mi, J., Zeng, X., & Cao, Y. (2021) · Foods · doi:10.3390/foods11010098 · Cited by 63
“A HFD impairs intestinal barrier function and increases intestinal permeability [35], resulting in a higher level of LPS in the blood, finally triggering systemic inflammation in different organs.”
BackgroundRecent advances in oral insulin delivery technologies
Zhang, E., Zhu, H. J., Song, B., Shi, Y., & Cao, Z. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.045 · Cited by 65
Szilagyi, A. (2019) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-019-01037-y · Cited by 65
Chen, J., Wang, M., Zhang, P., Li, H., Qu, K., Xu, R.-M., Guo, N., & Zhu, H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106191 · Cited by 66
Gut microbiota and obesity: New insights
Sarmiento-Andrade, Y., Suárez, R., Quintero, B., Garrochamba, K., & Chapela, S. P. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1018212 · Cited by 71
Zhang, L., Liu, Y., Sun, Y., & Zhang, X. (2022) · Nutrients · doi:10.3390/nu14224774 · Cited by 66
“T2D has also been considered to be under the influence of the dysregulated GM composition and functionality.”
BackgroundInfluentialDiabetes as a risk factor for MASH progression
Gancheva, S., Roden, M., & Castéra, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111846 · Cited by 65
Central metabolic interactions of immune cells and microbes: prospects for defeating infections
Traven, A., & Naderer, T. (2019) · EMBO Reports · doi:10.15252/embr.201947995 · Cited by 62
“Increased blood glucose levels trigger glucose transporter-mediated transcriptional reprogramming of epithelial cells, which causes loss of gut barrier integrity and infections [54].”
Wang, Y., Yang, J., Wang, W., Sanidad, K. Z., Cinelli, M. A., Wan, D., Hwang, S. H., Kim, D., Lee, K. S. S., Xiao, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916189117 · Cited by 59
“However, the molecular mechanisms leading to intestinal barrier dysfunction are not well understood, and currently there are no available therapeutic approaches for prevention and/or treatment (8, 9).”
BackgroundLv, W., Graves, D. T., He, L., Shi, Y., Deng, X., Zhao, Y., Dong, X., Yi, R., Liu, X., Xiao, E., et al. (2020) · Theranostics · doi:10.7150/thno.44113 · Cited by 60
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
Snelson, M., Lucut, E., & Coughlan, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031766 · Cited by 63
“Recent evidence has shown that hyperglycaemia, a driver of endogenous AGE formation, can drive disruption of the intestinal barrier [12,13].”
BackgroundGenetic liability to obesity and peptic ulcer disease: a Mendelian randomization study
Li, Z., Chen, H., & Chen, T. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01366-x · Cited by 62
“Recent studies have linked obesity to mucosal dysfunction [33, 34], which is one of the potential mechanisms associated with PUD [35].”
BackgroundType 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 65
“Consequently, hyperglycemia and glucotoxicity result from pancreatic dysfunction, increase intestinal permeability, and activate the inflammatory response.(53,58)”
BackgroundYe, J., Wu, Z., Zhao, Y., Zhang, S., Liu, W.-T., & Su, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1029890 · Cited by 64
Healthy Gut, Healthy Bones: Targeting the Gut Microbiome to Promote Bone Health
Cooney, O. D., Nagareddy, P. R., Murphy, A. J., & Lee, M. K. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.620466 · Cited by 63
“Metabolic diseases such as diabetes and obesity have also been linked to increased intestinal permeability, which again is involved in further increasing inflammation (31, 32).”
BackgroundBai, Z., Huang, X., Wu, G., Zhang, Y. L., Xu, H., Chen, Y., Yang, H., & Nie, S. (2023) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2023.108670 · Cited by 58
Insights on β-glucan as a prebiotic coadjuvant in the treatment of diabetes mellitus: A review
Sivieri, K., de Oliveira, S. M., Marquez, A. D. S., Pérez‐Jiménez, J., & Diniz, S. N. (2022) · Food Hydrocolloids for Health · doi:10.1016/j.fhfh.2022.100056 · Cited by 56
Phytate metabolism is mediated by microbial cross-feeding in the gut microbiota
de Vos, W. M., Trung, M. N., Davids, M., Liu, G., Ríos-Morales, M., Jessen, H. J., Fiedler, D., Nieuwdorp, M., & Bui, T. P. N. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01698-7 · Cited by 65
“Intestinal barrier disruption may lead to systemic infectious and inflammatory consequences of obesity and diabetes 50 .”
Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice
Schroeder, B. O., Birchenough, G. M. H., Pradhan, M., Nyström, E. E. L., Henricsson, M., Hansson, G. C., & Bäckhed, F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015771 · Cited by 60
“Support for the hypothesis that barrier dysfunction is secondary to metabolic impairments has been obtained from a comprehensive study that included several mouse models of obesity and glucose metabolism(35).”
BackgroundLuo, Z., Ji, Y., Zhang, D., Gao, H., Jin, Z., Yang, M., & Ying, W. (2022) · Acta Physiologica · doi:10.1111/apha.13827 · Cited by 61
Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo‐Repo, M., Nurmi, K., & Eklund, K. K. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02946-z · Cited by 57
Border Control: The Role of the Microbiome in Regulating Epithelial Barrier Function
Schreiber, F., Balas, I., Robinson, M. J., & Bakdash, G. (2024) · Cells · doi:10.3390/cells13060477 · Cited by 58
Marroncini, G., Naldi, L., Martinelli, S., & Amedei, A. (2024) · Biomedicines · doi:10.3390/biomedicines12071398 · Cited by 60
Jadhav, K. S., & Cohen, T. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.592157 · Cited by 57
“absolved the gut microbiome of any culpability in IR-driven gut permeability (84).”
BackgroundInfluentialAwoyemi, A., Trøseid, M., Arnesen, H., Solheim, S., & Seljeflot, I. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-018-0360-3 · Cited by 55
Microbiome dynamics in obesity
Thaiss, C. A. (2018) · Science · doi:10.1126/science.aav6870 · Cited by 57
Self-citationThe Influence of the Western Diet on Microbiota and Gastrointestinal Immunity
Heras, V. L., Melgar, S., MacSharry, J. A., & Gahan, C. G. M. (2022) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-052720-011032 · Cited by 53
Gudan, A., Kozłowska‐Petriczko, K., Wunsch, E., Bodnarczuk, T., & Stachowska, E. (2023) · Nutrients · doi:10.3390/nu15061323 · Cited by 58
“and hyperglycemia are diagnosed among patients with NAFLD [33,34]; therefore, intestinal barrier disruption and intestinal permeability may equally result from these mechanisms.”
BackgroundFeei, Z., Fu, C., & Lee, Y. Y. (2025) · Foods · doi:10.3390/foods14050821 · Cited by 59
“In obesity and insulin resistance, hyperglycaemia can increase gut permeability, triggering an inflammatory cascade that worsens metabolic dysfunction [115].”
Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation
Cheru, L., Saylor, C. F., & Lo, J. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00332-6 · Cited by 57
Glucose alters the symbiotic relationships between gut microbiota and host physiology
Anhê, F. F., Barra, N. G., & Schertzer, J. D. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00485.2019 · Cited by 58
“These results extend into humans demonstrating that systemic influx of intestinal microbial products correlated with glycated hemoglobin levels (42) (Fig.”
BackgroundResultDairy starters and fermented dairy products modulate gut mucosal immunity
Illikoud, N., Mantel, M., Rolli‐Derkinderen, M., Gagnaire, V., & Jan, G. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.11.002 · Cited by 55
Zou, T., Xie, F., Liang, P., Chen, J., Wang, Z., Du, ., & You, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114034 · Cited by 54
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.